Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06797752 · ClinicalTrials.gov registry record
Effect of the Stellate Ganglion Block on the Retinal Microcirculation
A clinical trial of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06797752 is a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 50 participants, below the 1,174-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06797752, a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain injury. One of these possible mechanisms include diffuse vasospasm that cause cerebral ischemia. Hence, methods to abrogate the sympathetic nervous system in this context are under active investigation. One possible method is the regional anesthesia technique of the stellate ganglion nerve block, which is ordinarily used for complex regional pain syndrome, but has been shown to reduce cerebral sympathetic activity and reduces vasospasm in patients with subarachnoid hemorrhage. However, its effect on the microcirculation is not clear. Hence, we propose to study patients receiving the stellate ganglion nerve block as part of their standard medical care and to image their retinal microcirculation before and after the procedure using Optical Coherence Tomography Angiography (OCTA).
Conditions Studied
Interventions
- DEVICE OCTA Scan
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2026-10-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06797752
The ClinicalTrials.gov registry entry for NCT06797752 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,174-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (96% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which OCTA Scan is the first listed.
NCT06797752 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06797752 about?
NCT06797752 is a clinical study titled "Effect of the Stellate Ganglion Block on the Retinal Microcirculation". Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain i...
What is the current status of trial NCT06797752?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-10-07. Estimated completion is 2026-10-07.
What conditions does trial NCT06797752 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Octa, Severe Brain Injury.
What interventions are being tested in trial NCT06797752?
The interventions under investigation include: OCTA Scan (DEVICE).
Who is sponsoring clinical trial NCT06797752?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06797752 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
ROSE-Longitudinal Assessment With Neuroimaging
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.